Younossi, Zobair M <br/><br/>
Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis.  [electronic resource] 

 -  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association  03 2017 
 - 421-430.e6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1542-7714 
<br/><br/><label>Standard No.: </label>10.1016/j.cgh.2016.10.037  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antiviral Agents--therapeutic use<br/>Carbamates--therapeutic use<br/>Clinical Trials, Phase III as Topic<br/>Drug Therapy, Combination--methods<br/>Female<br/>Hepatitis C, Chronic--complications<br/>Heterocyclic Compounds, 4 or More Rings--therapeutic use<br/>Humans<br/>Liver Cirrhosis<br/>Male<br/>Middle Aged<br/>Patient Reported Outcome Measures<br/>Ribavirin--therapeutic use<br/>Sofosbuvir--therapeutic use<br/>Surveys and Questionnaires<br/>Sustained Virologic Response<br/>Treatment Outcome